Clinical Trial Update: Adjunctive Treatment With Vitamin D3 in Patients With Active IBD [NA]

View source ↗

Summary

A clinical trial evaluating adjunctive vitamin D3 in patients with active inflammatory bowel disease has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• Cholecalciferol (Vitamin D3) (cholecalciferol)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: IBD, Inflammatory Bowel Diseases | NA | Status: SUSPENDED